Scholar goes to the clinic

While Scholar Rock LLC’s series C round will bring the biotech’s lead program into the clinic, investors also want continued investment in the company’s growth factor modulation platform to maximize its value.

On Jan. 3, Scholar Rock raised $47 million in a series C round led by new investor Invus. New investor Redmile Group and existing investors Polaris Partners, Timothy Springer, Arch Venture Partners, EcoR1 Capital, The Kraft Group, Fidelity and Cormorant Asset Management also participated. ...